In 2003, the German Cancer Society (Deutsche Krebsgesellschaft, DKG) launched a certification program aimed at improving the quality of cancer care.

First-line treatment of patients with recurrent, metastatic prostate cancer involves hormone therapy with or without additional systemic therapies.

Prior studies suggest that nationally endorsed quality measures for prostate cancer care are not linked closely with outcomes. Using a prospective...

To report our experience and lessons learned as high-volume center of robotic surgery managing patients with prostate cancer since the beginning of...

Men with advanced prostate cancer (APC) face multiple challenges including poor prognosis, poor health- related quality of life (HRQOL), and elevated...

Although a growing body of evidence supports an early-life contribution to prostate cancer development, few studies have investigated early-life diet

Promotion of a healthy lifestyle in patients with prostate cancer has gained traction to increase patient investment in his/her health care practices...

This guideline provides recommendations for available tissue-based prostate cancer biomarkers geared toward patient selection for active surveillance